[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356182-105":59,"doc-detail-356182-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","detection-of-tumor-suppressor-genes-rare-variants-findings-from-neuroblastoma-using-next-generation-sequencing","Detection of Tumor Suppressor Genes Rare Variants: Findings From Neuroblastoma Using Next-Generation Sequencing","","Neuroblastoma progression is strongly shaped by genetic alterations, particularly changes in tumor suppressor genes (TSGs) that normally regulate cell growth, limit replication, and trigger apoptosis. This study identifies TSG variants in 102 neuroblastoma patients managed under the International Neuroblastoma Risk Group Staging System protocol. DNA from paraffin-embedded tissues was analyzed using Next-Generation Sequencing with the Pillar ONCO/Reveal Multi-Cancer v4 panel. Results highlighted recurrent RB1 p.P793S and ATM p.D1853N, alongside stop-gain variants in TP53, FBXW7, and PTEN.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/detection-of-tumor-suppressor-genes-rare-variants-findings-from-neuroblastoma-using-next-generation-sequencing/356182/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/detection-of-tumor-suppressor-genes-rare-variants-findings-from-neuroblastoma-using-next-generation-sequencing/356182.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the study on neuroblastoma genetics?","Question",{"text":112,"@type":113},"The study aims to identify tumor suppressor gene (TSG) variants in neuroblastoma patients and evaluate their clinical significance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were TSG variants detected in the 102 neuroblastoma patients?",{"text":117,"@type":113},"DNA was extracted from paraffin-embedded tissue samples, and Next-Generation Sequencing was performed using the Pillar ONCO/Reveal Multi-Cancer v4 panel.",{"name":119,"@type":110,"acceptedAnswer":120},"Which tumor suppressor gene variants were most frequently recurring, and which stop-gain genes were identified?",{"text":121,"@type":113},"The most frequent finding was RB1 p.P793S, followed by ATM p.D1853N. Stop-gain variants were identified in TP53 (p.R196*), FBXW7 (p.R367*), and PTEN (p.G129*).",{"name":123,"@type":110,"acceptedAnswer":124},"What do the conclusions suggest about the relevance of TSG variants in neuroblastoma?",{"text":125,"@type":113},"The findings emphasize the significance of specific TSG variants for disease progression and potential prognostic markers, with a need for further work on germline variants and protein expression in larger cohorts.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},356182,1790198029,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Detection of Tumor Suppressor Genes Rare Variants: Findings From Neuroblastoma Using Next-Generation Sequencing  \nAylin Erol 1, Deniz Kızmazoğlu 1, Tekincan Çağrı Aktaş 1,Özde Elif Gökbayrak 1, and Safiye Aktaş 1  \nPediatric and Developmental Pathology 2026, Vol. 29(5) 493–500  \n© 2026, Society for Pediatric Pathology All rights reserved  \nArticle reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10935266251413938](DOI: 10.1177/10935266251413938)[ ](DOI: 10.1177/10935266251413938)[journals.sagepub.com/home/pdp](journals.sagepub.com/home/pdp)  \nAbstract  \nBackground/Objectives: Neuroblastomas (NB) influenced by genetic alterations, which plays significant role in disease progression. Tumor suppressor genes (TSGs) are crucial in regulating cell growth, suppressing replication, and inducing apoptosis to prevent cancer formation. However, mutations in TSGs can lead to loss of normal activity, contributing to cancer development. This study aimed to identify TSG variants in NB patients and assess their clinical significance. Methods: One hundred two NB patients diagnosed and monitored according to the International Neuroblastoma Risk Group Staging System (INRGSS) protocol were included in this study. DNA was extracted from paraffin-embedded tissue samples, and Next-Generation Sequencing (NGS) was conducted using the Pillar ONCO/Reveal Multi-Cancer v4 panel. Results: The most frequently recurring TSG variant detected was RB1, p.P793S (n = 21; 25%) followed by ATM, p.D1853N (n = 20, 19.6%).  \nStop-gain variants were identified in TP53 (p.R196*), FBXW7 (p.R367*), and PTEN (p.G129*).  \nConclusions: Our findings underscore the significance of specific TSG variants in NB, particularly in relation to disease progression and potential prognostic markers. Further research is needed to comprehensively assess the role of TSGs in NB, with an emphasis on germline variants and protein expression in larger patient cohorts.  \nKeywords  \ntumor suppressor genes (TSGs), neuroblastoma (NB), next generation sequencing (NGS)  \nIntroduction  \nNeuroblastoma (NB) is a rare malignancy derived from the sympathetic nervous system of neural crest cells. The median age of NB diagnosis is 17 to 18 months,1 and genetic alterations distinguish it.2 Modifications in genetic expression play an important role in NB progression, influencing cellular processes such as growth.3 Investigations ofthe genetic basis of NB, encompassing driver genes such as MYCN, RAS, and ALK, utilize clinical and biological variables, like MYCN amplification and chromosomal modifications, to categorize distinct risk groups in NB.4 Children with high-risk NB frequently develop resistance to treatment because of tumor heterogeneity, resulting in recurrence and an unfavorable prognosis. The relevant therapeutic targets include anti-GD2 treatment and treatment forALK, AURKA, and PHOX2B.5,6 The updated 2021 risk classification system was made by the Children’s Oncology Group (COG), NB has different risk categories (low, intermediate, and high-risk) that are assigned to based on tumor burden, biology, and prognosis. Risk  \nassessment includes factors like patients age, tumor stage(L1, L2, M, and MS), surgical risk, imaging results, tumor differentiation grade, and biomarkers (MYCN oncogene amplification, DNA ploidy) .7,8 Every year, approximately 3000 cases of pediatric malignancy are identified in the Turkish Republic, with roughly 500 being NB.9 Fifty percent of these NB occurrences exhibit metastasis at the time of diagnosis.10 TSGsplay a crucial role in regulating cellular growth by inhibiting replication and promoting apoptosis, thereby preventing the development of cancer. These genes function essential of the genetic material, ensuring the stability of the genome and preventing the development of genetic alterations that may cause tumorigenesis. These genes operate through the preservation  \n1 Institute","cbCaihsn5cjjfsHL","https://ap.wps.com/l/cbCaihsn5cjjfsHL","pdf",517598,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Neuroblastoma background and risk assessment\n## Role of tumor suppressor genes and TP53\n# Patients and study design\n## Cohort and risk-group staging\n## Genomic sequencing approach\n# Findings\n## Recurrent TSG variants\n## Stop-gain variants in key genes\n# Implications and future research\n## Prognostic markers and larger cohorts","[{\"question\":\"What is the main aim of the study on neuroblastoma genetics?\",\"answer\":\"The study aims to identify tumor suppressor gene (TSG) variants in neuroblastoma patients and evaluate their clinical significance.\"},{\"question\":\"How were TSG variants detected in the 102 neuroblastoma patients?\",\"answer\":\"DNA was extracted from paraffin-embedded tissue samples, and Next-Generation Sequencing was performed using the Pillar ONCO/Reveal Multi-Cancer v4 panel.\"},{\"question\":\"Which tumor suppressor gene variants were most frequently recurring, and which stop-gain genes were identified?\",\"answer\":\"The most frequent finding was RB1 p.P793S, followed by ATM p.D1853N. Stop-gain variants were identified in TP53 (p.R196*), FBXW7 (p.R367*), and PTEN (p.G129*).\"},{\"question\":\"What do the conclusions suggest about the relevance of TSG variants in neuroblastoma?\",\"answer\":\"The findings emphasize the significance of specific TSG variants for disease progression and potential prognostic markers, with a need for further work on germline variants and protein expression in larger cohorts.\"}]","Detection of Tumor Suppressor Genes Rare Variants: Findings From Neuroblastoma Using Next-Generation Sequencing | PDF",1790123877,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34b968aa1b07aed53a44710d86d2b6fe.webp",983,1272,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74f66ce5cb35367b0e6cafddb4596c18.webp",982,1270,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f748d53e1e09874824cf040f037f578e.webp",981,1269,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6971a1473d4f8b1e882373d0afa87601.webp",980,1268]